Restricted accessLetterFirst published online 2023-02
Letter to the Editor: Effects of Add-On Metolazone to High-Dose Oral Frusemide on Refractory Fluid Overload in Patients with End-Stage Kidney Disease Opting for Conservative Management
O'ConnorNR, KumarP. Conservative management of end-stage renal disease without dialysis: A systematic review. J Palliat Med, 2012; 15(2):228–235; doi: 10.1089/jpm.2011.0207
2.
ChanKY, YipT, YapDYH, et al.A pilot comprehensive psychoeducation program for fluid management in renal palliative care patients: Impact on health care utilization. J Palliat Med, 2020; 23(11):1518–1524; doi: 10.1089/jpm.2019.0424
3.
NgTM, KonopkaE, HyderiAF, et al.Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. J Cardiovasc Pharmacol Ther, 2013; 18(4):345–353; doi: 10.1177/1074248413482755
4.
RosenbergJ, GustafssonF, GalatiusS, et al.Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: An observational study and review of the literature. Cardiovasc Drugs Ther, 2005; 19(4):301–306; doi: 10.1007/s10557-005-3350-2
